Zoom $ZM Earnings Preview
Zoom'ing into earnings this afternoon, $ZM is set to report its Q1 financials.

Analysts expect $1.07B in revenue and $0.88 in adj. EPS. Zoom has performed poorly this year, down 52%, but does it deserve this drawdown?

Let's take a look!

$ZM saw a spike in adoption during the pandemic, lumping it in with other "covid beneficiaries" in the eyes of investors.

However, $ZM has seen operating income increase over the past two years, whereas others in this group have been flat or declined.

Additionally, Zoom ZM generates significantly more free cash flow than some of the most popular SaaS stocks like $CRWD, $ZS, $NET, $SHOP, and $PLTR.

Zoom becomes an even clearer outlier when you look at its free cash flow relative to its market cap.

But everything has a catch!

Zoom has seen its revenue growth dwindle from a high of 368% to only 21.4%. Analysts expect this growth to slow again making it five straight quarters of declining growth.

At the end of the day, it's up to you, the investor, to decide if Zoom is undervalued.
What do you think?
15 VotesPoll ended on: 05/24/22
Long term holds (Portfolio breakdown)
I will be breaking down my top 10 positions in my portfolio and explaining why im planning to buy and hold for the next five years. Here are the stocks I plan to make the post from.
(Not in a specific order)

$ENPH - Solar
$PLTR - AI Data
$XDNA - Healthcare/Gene-editing
$RKLB - Space/Rockets
$MP - Materials (Treating it as a gold play)
$NVDA - Semiconductor /AI/SD (self driving)
$CRWD - Cybersecurity
$PSIL - Psychedelics
$ETHE - Ethereum (Crypto Play)
post media
All relevant, interesting corners of the market. Sounds like you have a well diversified set of holdings. Looking forward to your post!
View 1 more comment
Portfolio changes - update 7
Hello friends, I've been continuously evaluating my portfolio over the weekend and I want to share with you what my end actions/conclusions are:

  • I sold $AMPL. For those not familiar, Amplitude is a leader in product and behavioral analytics which puts seemingly random data into a perspective. They compete with players such as Mixpanel or Pendo. All of those are pretty strong competitors, which on its own isn't a deal breaker, in theory all of those could win simultaneously as the space is huge. But, those insights get sent over into CDPs or Customer Data Platforms. Customer data platforms are basically a software which combines the data from all sorts of tools - like Amplitude - to create a centralized customer database containing data on all touch points and interactions with the product/service. Segment is no.1 in the space, used by huge players, acquired recently by Twilio (which I own). Now I realize that regardless of whether Amplitude, Mixpanel or Pendo wins the customer, they are likely using Twilio already for at least something and so the network effects kick in. Therefore I decided to play this space through $TWLO which is more diverse and not focused on just one product, but instead has a lot of functionality and owns the top player in the CDP which is where that data from Amplitude and others comes from anyways. So I'll have exposure. I just prefer that upper layer over the end layer.

  • I spent basically the whole day yesterday trying to understand $SNOW better, evaluating their first mover advantage when it comes to data evolution in cloud vs legacy, their relationship with SMBs and overall the culture of the company. I'm very impressed and the company fits a lot of my checkmarks. Frank maybe isn't the most visible CEO out there, but I somewhat admire his laser focus on innovation, not getting too comfortable with yourself, ... basically pushing the limits at all times. Both $MDB and $SNOW fit many of investing themes I build my portfolio around and give me an exposure to broad set of customers, even better so to those just scaling up whose success will be reflected in the amount they pay to those because of their usage based pricing. $PLTR does something similar, but their Data Mesh is way more early in the process and Palantir overall has way less clients (although more capitalized) than those two. These 3 companies I believe are the best of breed when it comes to anything data. In conclusion, I essentially dismissed Snowflake due to the valuation since the listing, I knew something but not nearly as much as I do today. Now that I'm better informed I decided to add this one into my portfolio. This no doubt is a very HQ company!

  • I also added more shares of $PATH today as I believe this is an incredible opportunity to load up more shares of this incredible beast!
Portfolio changes - update '?'
Hey, I've been going through my portfolio once again, as I'm slowly doing the consolidation process, evaluating whether there's not too much of an overlap between my holdings. I think I reached a phase where I don't see anything too weak, but quite a lot of strong performing businesses I'm looking to add to, actually. I'm not saying I won't sell anything moving on, but even if I do it will be solely for the highest conviction add purposes/just better opportunities in the space.

  • I think it's worth mentioning I'm looking to open a position in $ZS, I think it's a tremendous company that fits nicely within my investing themes, mainly in the enterprise and CyberSec space. As I'm going more in-depth, I'll definitely be adding to $MDB which I bought recently, their optionality is just way beyond what it appears to be on the surface and I'm absolutely mind-blown by all the possibilities and diversification they have.

  • I was looking to go deeper into Life sciences/Biotech/Health, but since I'm no real expert there but still I'm very interested in the space and I believe it's the future, I'm going to play the industry through companies like $GOOGL (large investments in all sorts of biotech companies via Google Ventures), $HIMS which I consider more of a technology/commerce company within the health space (telemedicine combined with branded products, many sold as a recurring subscription sort of), and companies such as $MDB and $PLTR which literally offer their software platforms to pharma companies which utilize them for all sorts of stuff such as data & analytics, gene sequencing, ...

So far by doing all this consolidation, I went from 57 to 45 when it comes to number of holdings and expect that number to naturally fall further as those industries consolidate, there's some M&A activity going on in tough cash tight environment and as some business just don't perform as much as I had expected them to do, which will result in further forming of core names I'll be adding to and sticking to long-term.
Samuel Meciar's avatar
$8m follower assets
Portfolio changes - update 3
As you well know by now, I'm a huge proponent of transparency. And despite me sharing my portfolio publicly here which gets updated like every 1-2 days, I want to make sure I can tell you what I'm doing as close to real-time as I can. So here we go, shall we?

I put my money where my mouth is, which are my high conviction bets.

There's a few companies I'm still thinking about for various reasons, such as $ETSY $ADSK $TWLO and $PINS. I'll let you know about them when done with my thinking.

Stay strong! Have a great day!
Commonstock is a social network that amplifies the knowledge of the best investors, verified by actual track records for signal over noise. Community members can link their existing brokerage accounts and share their real time portfolio, performance and trades (by percent only, dollar amounts never shared). Commonstock is not a brokerage, but a social layer on top of existing brokerages helping to create more engaged and informed investors.